Michael Bayewitch, PhD named Head of BD and Licensing North America for Insilico Medicine
Insilico Medicine, a clinical-stage generative artificial intelligence (AI)-driven drug discovery company, has appointed Michael Bayewitch, PhD, as Head of Business ...